← Leaderboards
Eliot L Gardner
National Institute On Drug Abuse
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Drug Abuse
Same institution · by research overlap
Others in their field
Top investigators on “Preference”
- Wafaa M. El-Sadr · Columbia University Health Sciences$103,095,453
- Myron S Cohen · Family Health International$101,800,876
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$43,571,007
- Christine C Johnson · Henry Ford Health System$41,507,281
- Brian Kenneth Ahmedani · Henry Ford Health System$36,605,096
- Christian P Larsen · Emory University$34,465,404
Research focus
PreferencePre-ClinicalElectrical Stimulation Of The BrainPolymerase Chain ReactionImmunoblottingPharmaceutical PreparationsBiochemicalConditionIntravenousMicrodialysisCuesCravingIn VivoDopamineAddiction, DrugAnimal ModelBlotting, WesternAnimals, LaboratoryChromatography, High Pressure LiquidBrainExposure ToBehaviorAddictionProteins
Grant awards (20)
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$389,626
Z01 · FY2008 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$311,701
Z01 · FY2008 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$311,701
Z01 · FY2008 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$311,701
Z01 · FY2008 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$311,701
Z01 · FY2008 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models$462,553
Z01 · FY2007 · DA · contact PI
Basic brain mechanisms underlying drug addiction, craving, and relapse$370,042
Z01 · FY2007 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclinical models$370,042
Z01 · FY2007 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Preclinical models$370,042
Z01 · FY2007 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction$370,042
Z01 · FY2007 · DA · contact PI
GABAergic compounds for treating drug addiction: Preclin$0
Z01 · FY2006 · DA · contact PI
Glutamatergic compounds for treating drug addiction: Pre$0
Z01 · FY2006 · DA · contact PI
Slow-onset long-acting dopamine transport inhibitors for$0
Z01 · FY2006 · DA · contact PI
Basic brain mechanisms underlying drug addiction, cravin$0
Z01 · FY2006 · DA · contact PI
Dopamine D3 receptor antagonists for treating drug addic$0
Z01 · FY2006 · DA · contact PI
GABAergic compounds-treating drug addiction: Preclinical$0
Z01 · FY2005 · DA
Basic brain mechanisms--drug addiction, craving, relapse$0
Z01 · FY2005 · DA
Slow-onset long-acting dopamine transport inhibitors$0
Z01 · FY2005 · DA
Glutamatergic compounds for treating drug addiction$0
Z01 · FY2005 · DA
Dopamine D3 receptor antagonists-treating drug addiction$0
Z01 · FY2005 · DA